rhinovirus vaccine (Sanofi Pasteur/Imperial College London)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerhinovirus vaccine (Sanofi Pasteur/Imperial College London)
Drug Alias Namerhinovirus vaccine (Imperial College London/Apollo Therapeutic)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRhinovirus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImperial College London
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApollo Therapeutics LtdSanofi Pasteur SaImperial College London
Active IndicationsN/A
Inactive IndicationsRhinovirus infection

Other Information

ATC CodeN/A
Related LinksN/A